[Case study of interleukin-1 beta, tumor necrosis factor alpha and interleukin-6 production peripheral blood monocytes in patients with diabetes mellitus complicated by pulmonary tuberculosis]. 1992

K Tsukaguchi, and T Yoneda, and M Yoshikawa, and T Tokuyama, and A Fu, and K Tomoda, and N Narita, and Y Enoki, and M Tsukaguchi, and F Shirai
Second Department of Internal Medicine, Nara Medical University, Japan.

Patients with diabetes mellitus (DM) show an increased susceptibility to bacterial infections due to the presence of neutrophil dysfunction. Susceptibility to tuberculosis has also been reported in such patients, however, the reason remains unclear. This study measured the production of interleukin-1 beta (IL-1 beta), tumor necrosis factor alpha (TNF alpha) and interleukin-6 (IL-6) by the peripheral monocytes of patients diagnosed with pulmonary tuberculosis accompanied by DM (TB+DM) and patients without DM complications (TB) using age-matched, healthy control subjects for comparison. Also examined was the relationship between cytokine production and DM control. The results were as follows: (1) The production of IL-1 beta, TNF alpha and IL-6 in TB patients was significantly higher than that observed in the healthy control subjects. (2) The production of IL-1 beta, TNF alpha and IL-6 in TB+DM patients was significantly lower than that observed in the TB patients. (3) The production of IL-1 beta and TNF alpha in TB+DM patients with poor control was significantly lower than that observed in the patients with good control. (4) The TNF alpha production had a significant inverse correlation to HbA1c in the TB+DM patients. This study demonstrated that the production of cytokines is impaired in TB+DM patients and suggests a close correlation between tuberculosis immunity and DM.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

K Tsukaguchi, and T Yoneda, and M Yoshikawa, and T Tokuyama, and A Fu, and K Tomoda, and N Narita, and Y Enoki, and M Tsukaguchi, and F Shirai
June 1990, Arthritis and rheumatism,
K Tsukaguchi, and T Yoneda, and M Yoshikawa, and T Tokuyama, and A Fu, and K Tomoda, and N Narita, and Y Enoki, and M Tsukaguchi, and F Shirai
October 1990, Infection and immunity,
K Tsukaguchi, and T Yoneda, and M Yoshikawa, and T Tokuyama, and A Fu, and K Tomoda, and N Narita, and Y Enoki, and M Tsukaguchi, and F Shirai
October 1993, The Journal of clinical endocrinology and metabolism,
K Tsukaguchi, and T Yoneda, and M Yoshikawa, and T Tokuyama, and A Fu, and K Tomoda, and N Narita, and Y Enoki, and M Tsukaguchi, and F Shirai
July 1996, Diabetes,
K Tsukaguchi, and T Yoneda, and M Yoshikawa, and T Tokuyama, and A Fu, and K Tomoda, and N Narita, and Y Enoki, and M Tsukaguchi, and F Shirai
December 1991, Journal of neuroimmunology,
K Tsukaguchi, and T Yoneda, and M Yoshikawa, and T Tokuyama, and A Fu, and K Tomoda, and N Narita, and Y Enoki, and M Tsukaguchi, and F Shirai
June 2010, Journal of periodontal research,
K Tsukaguchi, and T Yoneda, and M Yoshikawa, and T Tokuyama, and A Fu, and K Tomoda, and N Narita, and Y Enoki, and M Tsukaguchi, and F Shirai
September 1992, Hepatology (Baltimore, Md.),
K Tsukaguchi, and T Yoneda, and M Yoshikawa, and T Tokuyama, and A Fu, and K Tomoda, and N Narita, and Y Enoki, and M Tsukaguchi, and F Shirai
September 1991, Journal of virology,
K Tsukaguchi, and T Yoneda, and M Yoshikawa, and T Tokuyama, and A Fu, and K Tomoda, and N Narita, and Y Enoki, and M Tsukaguchi, and F Shirai
March 1990, Blood,
K Tsukaguchi, and T Yoneda, and M Yoshikawa, and T Tokuyama, and A Fu, and K Tomoda, and N Narita, and Y Enoki, and M Tsukaguchi, and F Shirai
February 1996, American journal of respiratory and critical care medicine,
Copied contents to your clipboard!